Close Menu

CRISPR Excitement

Researchers and drug companies are enthusiastic about the use of genome editing tools like CRISPR-Cas9 to replace disease-causing genetic variants with healthy DNA stretches, the Wall Street Journal reports.

It cautions that therapies based on such approaches won't be available for years, if at all, but adds that they offer "tremendous potential for new treatments."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.